友成 哲医師による原著論文がHepatol Resに掲載されました。
Tomonari T, Shimose S, Saeki I, Tani J, Honma Y, Ito T, Takeuchi M, Naito T, Takeuchi Y, Sasaki R, Sasaki K, Hatanaka T, Kakizaki S, Kanayama Y, Naganuma A, Tanabe N, Tanaka H, Kawano Y, Sato Y, Nishina S, Miyaaki H, Otsuka M, Kawashima H, Harada M, Kobara H, Takami T, Kawaguchi T, Takayama T; Hepatology InVestigator Experts in Japan (HIVE‐J) Study Group.
A novel approach to evaluate the therapeutic efficacy of durvalumab and tremelimumab combination therapy in hepatocellular carcinoma.
Hepatol Res. 2025 May 28. doi: 10.1111/hepr.14212. Online ahead of print.
注：下線は当講座の医局員
